NHS England – 30 day public consultation

NHS England has launched a 30 day public consultation on a proposed number of new products to include Selexipag and Riociguat in the treatment of Pulmonary Arterial Hypertension. It is a way for patients to engage with relevant national policy.

https://www.engage.england.nhs.uk/consultation/clinical-commissioning-wave6